Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Diane Reidy-Lagunes

GI Oncology · Duke University

View

Dr. Tyler Johnson

GI Oncology · Stanford

View

Dr. James Cleary

GI Oncology · Dana-Farber Cancer Institute

View

Dr. Thorvardur Halfdanarson

GI Oncology · Mayo Clinic Rochester

View

Dr. Linette Bosques

GI Oncology · DFCI/MGB

View

Dr. Shikha Jain

GI Oncology · University Illinois

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ELDr. Emil Lou

    Dr. Emil Lou

    Hematology & Oncology · Gastrointestinal Oncology
    University of Minnesota
    emil

    Research

    Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy

    2026

    Via NPJ Precision Oncology

    Research

    CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints

    2026

    Via Communications Biology

    Research

    Age- and sex-based differences in the genomic profiles of patients with gastrointestinal and pancreatic neuroendocrine neoplasms

    2026

    Via The Oncologist

    Research

    STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer

    2026

    Via BJC Reports

    Research

    Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer

    2026

    Via NPJ Precision Oncology

    Research

    Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future development

    2026

    Via Molecular Therapy. Oncology

    Research

    CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer

    2026

    Via BMJ Oncology

    Research

    The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)

    2026

    Via Cancer Treatment and Research Communications

    Research

    Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV)

    2026

    Via Infectious Agents and Cancer

    Research

    Immunotherapy with guts: a review of microbial therapeutic adjuncts for immunotherapy in solid tumors

    2026

    Via The Oncologist

    Research

    Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy

    2026

    Via Cancer Immunology, Immunotherapy

    Research

    Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes

    2026

    Via Cell Reports. Medicine

    Research

    Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors

    2025

    Via Scientific Reports

    Research

    Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy

    2025

    Via ESMO Open

    Research

    Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma

    2025

    Via BMJ Oncology